HighTower Advisors’s Compugen CGEN Stock Holding History

HighTower Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,000	Closed	-$3K	–	2635
2020 Q3	$3K	Buy	+5,000	New	+$81.9K	﹤0.01%	2480

Other funds holding CGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

HighTower Advisors's CGEN Position: Q4 2022 in Review

HighTower Advisors sold out of Compugen (CGEN) in Q4 2022, closing a stake of 37,400 shares — an estimated $23K sold.

HighTower Advisors first reported a position in CGEN in Q1 2014 and held it in 12 quarters. The position peaked at $409K in Q3 2020. 74 funds tracked by Wall St. Rank hold CGEN as of Q4 2022.

HighTower Advisors reported no remaining Compugen position as of Q4 2022 after selling out during the quarter.
HighTower Advisors sold 37,400 Compugen shares in Q4 2022, an estimated $23K.
HighTower Advisors first reported a position in Compugen in Q1 2014 and held it in 12 quarters.
HighTower Advisors's Compugen position peaked at $409K in Q3 2020.
74 funds tracked by Wall St. Rank held Compugen as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.